Allurion Technologies (ALURD) Non Operating Income (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Non Operating Income came in at -$2.3 million in Q1 2026, down 139.86% YoY from $5.9 million in Q1 2025, and down 1359.14% on a QoQ basis from $186000.0 in Q4 2025.
Allurion Technologies (ALURD) Non Operating Income (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Non Operating Income data on file, last reported at -$2.3 million in Q1 2026.
- Quarterly Non Operating Income fell 139.86% year-over-year to -$2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.7 million (down 118.66% YoY) and the FY2025 annual result came in at $1.5 million, down 96.62% from the prior year.
- Non Operating Income declined to -$2.3 million in Q1 2026, from $186000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $21.1 million in Q3 2024 to a low of -$8.7 million in Q2 2023.
- A 5-year average of $2.2 million and a median of -$463000.0 in 2022 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2023 — Non Operating Income plunged 680.58% — and 2024, when it soared 447.32%.
- Tracing ALURD's Non Operating Income over 5 years: stood at -$2.2 million in 2022, then surged by 310.13% to $4.5 million in 2023, then soared by 77.24% to $8.0 million in 2024, then sank by 97.68% to $186000.0 in 2025, then tumbled by 1359.14% to -$2.3 million in 2026.
- The last three Non Operating Income figures came in at -$2.3 million (Q1 2026), $186000.0 (Q4 2025), and -$2.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 46.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | -2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.34 Mn |
| Dec 31, 2025 | 186,000.00 |
| Sep 30, 2025 | -2.25 Mn |
| Jun 30, 2025 | -2.34 Mn |
| Mar 31, 2025 | 5.88 Mn |
| Dec 31, 2024 | 8.02 Mn |
| Sep 30, 2024 | 21.15 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 13.46 Mn |
| Dec 31, 2023 | 4.52 Mn |
| Sep 30, 2023 | 4.56 Mn |
| Jun 30, 2023 | -8.68 Mn |
| Mar 31, 2023 | -3.88 Mn |
| Dec 31, 2022 | -2.15 Mn |
| Sep 30, 2022 | -1.49 Mn |
| Jun 30, 2022 | -1.11 Mn |